Patent ID: 8889188
Filing Date: 2014-11-18
Classification: A61K,A61P,Y10S

Abstract:
1. A low power three-dimensional (3D) self-assembled conducting photoluminescent nanomedicine, comprising: 3D unitary, binary, ternary, and quaternary nanomedicine crystals of isoprenaline, adenosine triphosphate, verapamil, and superoxide dismutase, in a L the 3D unitary, binary, ternary, and quaternary nanomedicine crystals disposed on a substrate of graphite and/or silicon, wherein the 3D unitary, binary, ternary, and quaternary nanomedicine crystals have a length from 400 nm to 1000 nm, a width from 400 nm to 1000 nm, and a height from 0.3 nm to 95 nm, and the low power three-dimensional (3D) self-assembled conducting photoluminescent nanomedicine has an inelastic electron tunneling property, a conducting property having a range of 1-8 μeV, and a photoluminescent property having a maximum photoluminescence intensity at 2000 absorbance units, a photoluminescence bandwidth covering 450-750 nm, and a central photoluminescence peak being located around 550 nm after subtraction of a background signal.